New and old challenges of sports drug testing

Journal of Mass Spectrometry

Volumn 43, Issue 7, 2008, Pages 903-907

  Botrè, Francesco ^a,b  

^a Laboratorio Antidoping   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antidoping analysis; Gas chromatography mass spectrometry; Isotopic ratio mass spectrometry; Liquid chromatography mass spectrometry; Sport doping

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; ANABOLIC AGENT; ANDROSTENEDIONE; ANTIESTROGEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANNABIS; CLENBUTEROL; COCAINE; DIURETIC AGENT; EPITESTOSTERONE; ERYTHROPOIETIN; FORMOTEROL; GONADOTROPIN DERIVATIVE; HUMAN GROWTH HORMONE; INSULIN DERIVATIVE; METHYLTESTOSTERONE; MORPHINE; NANDROLONE; PROBENECID; SALBUTAMOL; SALMETEROL; SELECTIVE ANDROGEN RECEPTOR MODULATOR; SOMATOMEDIN; STANOZOLOL; STEROID 5ALPHA REDUCTASE INHIBITOR; STRYCHNINE; TERBUTALINE; TESTOSTERONE; UNINDEXED DRUG;

ANALYTIC METHOD; DOPING; GAS CHROMATOGRAPHY; LABORATORY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NOTE; PRIORITY JOURNAL;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPING IN SPORTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INTERNATIONALITY; ISOTOPE LABELING; SPORTS; SUBSTANCE ABUSE DETECTION;

EID: 47749104941     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.1455     Document Type: Note

References (20)

1. World Anti-Doping Agency. The world anti-doping code. The 2008 prohibited list international standard. Montreal (Canada), (available online through the WADA website at www.wada-ama.org, last accessed March 31st 2008).
2. Trout GJ, Kazlauskas R. Sport drugs Testing - an analyst's perspective. Chemical Society Reviews 2004; 33: 1.
3. Cowan DA, Kicman AT. Doping in sport: misuse, analytical tests, and legal aspects. Clinical chemistry 1997; 43: 1110.
4. Segura J. Sports. In Drug abuse handbook, Karch SB (ed). CRC Press: Boca Raton (USA) 1998; 641.
5. Thevis M, Schänzer W. Mass spectrometric identification of peptide hormones in doping-control analysis. The Analyst 2007; 132: 287.
6. Thevis M, Thomas A, Schänzer W. Mass spectrometric determination of insulins and their degradation products in sports drug testing. Mass Spectrometry Reviews 2008; 27: 35.
7. Aguilera R, Becchi M, Casabianca H, Hatton CK, Catlin DH, Starcevic B, Pope HG Jr. Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids. Journal of Mass Spectrometry 1996; 31: 169.
8. Lasne F, Martin L, Crepin N, de Ceaurriz J. Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones. Analytical Biochemistry 2002; 311: 119.
9. Catlin DH, Ahrens BD, Kucherova Y. Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine. Rapid Communications in Mass Spectrometry 2002; 16: 1273.
10. Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang YC, Hatton CK. Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Communications in Mass Spectrometry 2004; 18: 1245.
11. Sekera MH, Ahrens BD, Chang YC, Starcevic B, Georgakopoulos C, Catlin DH. Another designer steroid: discovery, synthesis, and detection of 'madol' in urine. Rapid Communications in Mass Spectrometry 2005; 19: 781.
12. Thevis M, Kamber M, Schänzer W. Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes. Rapid Communications in Mass Spectrometry 2006; 20: 870.
13. Thevis M, Geyer H, Mareck U, Schänzer W. Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry. Journal of Mass Spectrometry 2005; 40: 955.
14. Georgakopoulos C, Vonaparti A, Stamou M, Kiousi P, Lyris PE, Angelis Y, Tsoupras G, Wuest B, Nielen MWF, Panderi I, Koupparis M. Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids. Rapid Communications in Mass Spectrometry 2007; 27: 2439.
15. Thevis M, Schänzer W. Current role of LC-MS(/MS) in doping control. Analytical and Bioanalytical Chemistry 2007; 388: 1351.
16. Mazzarino M, Turi S, Botrè F. A screening method for the detection of synthetic glucocorticosteroids in human urine by liquid chromatography - mass spectrometry based on class-characteristic fragmentation pathways. Analytical and Bioanalytical Chemistry 2008; 390: 1389.
17. Köhler M, Ayotte C, Desharnais P, Flenker U, Lüdke S, Thevis M, Völker-Schänzer E, Schänzer W. Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels. International Journal of Sports Medicine 2008; 29: 1.
18. Barroso O, Mazzoni I, Rabin O. Hormone abuse in sports: the antidoping perspective. Asian Journal of Andrology 2008; 10: 391.
19. Botrè F. Drugs of abuse and abuse of drugs in sportsmen: the role of in vitro methods to study effect and mechanism. Toxicology in Vitro 2003; 17: 509.
20. Botrè F, Pavan A. Enhancement drugs and the athlete. Neurologic Clinics 2008; 26: 149.